(EUFN) iShares MSCI Europe - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US4642891802 • Financial

EUFN: Banks, Insurance, Investments, Financial Services

The iShares MSCI Europe Financials ETF (NASDAQ: EUFN) is a targeted investment vehicle designed to track the performance of the financial sector across developed European markets. The fund adheres to a strict investment policy, allocating at least 80% of its assets to securities within its underlying index or to investments that mirror the economic characteristics of those securities. This ensures a high level of alignment with the indexs performance, making it a precise tool for investors seeking exposure to Europes financial sector.

The underlying index, the MSCI Europe Financials Index, is a free float-adjusted, market capitalization-weighted benchmark. It captures the collective equity performance of publicly traded financial companies in developed European markets. By focusing on market capitalization weighting, the index inherently allocates more weight to larger, more established financial institutions, which often have greater market influence and stability. The free float adjustment ensures that only the shares available for public trading are considered, aligning the index more closely with the actual investable market.

Domiciled in the United States, the ETF is listed on the NASDAQ exchange under the ticker symbol EUFN. This structure allows U.S. investors to gain exposure to European financial markets with the ease of trading a domestic security. The fund falls under the Financial category of ETFs, making it a niche product for investors seeking targeted sector exposure rather than broad market coverage.

With an AUM of $2.16 billion, EUFN is a sizeable fund, indicating significant investor interest and liquidity. Its expense ratio of 0.48% is competitive for a Europe-focused financial sector ETF, balancing cost efficiency with targeted exposure. The fund holds approximately 70 constituents, providing diversification across the European financial landscape while avoiding excessive concentration in any single company or region.

The ETFs portfolio spans a range of financial subsectors, including banking, insurance, and asset management. This diversification within the financial sector reduces reliance on any one area

Additional Sources for EUFN ETF

EUFN ETF Overview

Market Cap in USD 2,535m
Category Financial
TER 0.51%
IPO / Inception 2010-01-20

EUFN ETF Ratings

Growth 5y 87.1%
Fundamental -
Dividend 72.6%
Rel. Strength Industry 12.7
Analysts -
Fair Price Momentum 31.15 USD
Fair Price DCF -

EUFN Dividends

Dividend Yield 12m 4.80%
Yield on Cost 5y 10.64%
Annual Growth 5y 38.83%
Payout Consistency 89.7%

EUFN Growth Ratios

Growth Correlation 3m 85.9%
Growth Correlation 12m 88.2%
Growth Correlation 5y 85.9%
CAGR 5y 19.71%
CAGR/Max DD 5y 0.56
Sharpe Ratio 12m 1.99
Alpha 30.34
Beta 0.63
Volatility 16.17%
Current Volume 3443.4k
Average Volume 20d 1404.9k
What is the price of EUFN stocks?
As of March 06, 2025, the stock is trading at USD 28.82 with a total of 3,443,400 shares traded.
Over the past week, the price has changed by +4.76%, over one month by +13.33%, over three months by +19.68% and over the past year by +42.31%.
Is iShares MSCI Europe a good stock to buy?
Yes. Based on ValueRay Analyses, iShares MSCI Europe (NASDAQ:EUFN) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 87.14 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EUFN as of March 2025 is 31.15. This means that EUFN is currently overvalued and has a potential downside of 8.08%.
Is EUFN a buy, sell or hold?
iShares MSCI Europe has no consensus analysts rating.
What are the forecast for EUFN stock price target?
According to ValueRays Forecast Model, EUFN iShares MSCI Europe will be worth about 35.9 in March 2026. The stock is currently trading at 28.82. This means that the stock has a potential upside of +24.5%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 35.9 24.5%